259 related articles for article (PubMed ID: 15655523)
1. Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors.
Atack JR; Hutson PH; Collinson N; Marshall G; Bentley G; Moyes C; Cook SM; Collins I; Wafford K; McKernan RM; Dawson GR
Br J Pharmacol; 2005 Feb; 144(3):357-66. PubMed ID: 15655523
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
Atack JR; Maubach KA; Wafford KA; O'Connor D; Rodrigues AD; Evans DC; Tattersall FD; Chambers MS; MacLeod AM; Eng WS; Ryan C; Hostetler E; Sanabria SM; Gibson RE; Krause S; Burns HD; Hargreaves RJ; Agrawal NG; McKernan RM; Murphy MG; Gingrich K; Dawson GR; Musson DG; Petty KJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):470-84. PubMed ID: 19704033
[TBL] [Abstract][Full Text] [Related]
3. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
[TBL] [Abstract][Full Text] [Related]
4. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.
Atack JR
Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):213-32. PubMed ID: 12871032
[TBL] [Abstract][Full Text] [Related]
5. Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice?
Mirza NR; Nielsen EØ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1378-85. PubMed ID: 16352707
[TBL] [Abstract][Full Text] [Related]
6. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
8. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.
Savić MM; Clayton T; Furtmüller R; Gavrilović I; Samardzić J; Savić S; Huck S; Sieghart W; Cook JM
Brain Res; 2008 May; 1208():150-9. PubMed ID: 18394590
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist.
Atack JR; Hallett DJ; Tye S; Wafford KA; Ryan C; Sanabria-Bohórquez SM; Eng WS; Gibson RE; Burns HD; Dawson GR; Carling RW; Street LJ; Pike A; De Lepeleire I; Van Laere K; Bormans G; de Hoon JN; Van Hecken A; McKernan RM; Murphy MG; Hargreaves RJ
J Psychopharmacol; 2011 Mar; 25(3):329-44. PubMed ID: 20156926
[TBL] [Abstract][Full Text] [Related]
10. 6,2'-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site.
Wang F; Xu Z; Yuen CT; Chow CY; Lui YL; Tsang SY; Xue H
Neuropharmacology; 2007 Sep; 53(4):574-82. PubMed ID: 17681556
[TBL] [Abstract][Full Text] [Related]
11. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
[TBL] [Abstract][Full Text] [Related]
12. The in vivo properties of pagoclone in rat are most likely mediated by 5'-hydroxy pagoclone.
Atack JR; Pike A; Marshall G; Stanley J; Lincoln R; Cook SM; Lewis RT; Blackaby WP; Goodacre SC; McKernan RM; Dawson GR; Wafford KA; Reynolds DS
Neuropharmacology; 2006 May; 50(6):677-89. PubMed ID: 16430927
[TBL] [Abstract][Full Text] [Related]
13. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.
Smith AJ; Alder L; Silk J; Adkins C; Fletcher AE; Scales T; Kerby J; Marshall G; Wafford KA; McKernan RM; Atack JR
Mol Pharmacol; 2001 May; 59(5):1108-18. PubMed ID: 11306694
[TBL] [Abstract][Full Text] [Related]
14. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
Atack JR
Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
[TBL] [Abstract][Full Text] [Related]
15. An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.
Dawson GR; Maubach KA; Collinson N; Cobain M; Everitt BJ; MacLeod AM; Choudhury HI; McDonald LM; Pillai G; Rycroft W; Smith AJ; Sternfeld F; Tattersall FD; Wafford KA; Reynolds DS; Seabrook GR; Atack JR
J Pharmacol Exp Ther; 2006 Mar; 316(3):1335-45. PubMed ID: 16326923
[TBL] [Abstract][Full Text] [Related]
16. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.
Atack JR; Bayley PJ; Seabrook GR; Wafford KA; McKernan RM; Dawson GR
Neuropharmacology; 2006 Nov; 51(6):1023-9. PubMed ID: 17046030
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
Knoflach F; Benke D; Wang Y; Scheurer L; Lüddens H; Hamilton BJ; Carter DB; Mohler H; Benson JA
Mol Pharmacol; 1996 Nov; 50(5):1253-61. PubMed ID: 8913357
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine and beta-carboline interactions with GABAA receptor-gated chloride channels in mammalian cultured spinal cord neurons.
Mehta AK; Ticku MK
J Pharmacol Exp Ther; 1989 May; 249(2):418-23. PubMed ID: 2542529
[TBL] [Abstract][Full Text] [Related]
20. Evidence that long-lasting potentiation of amygdala efferents in the right hemisphere underlies pharmacological stressor (FG-7142) induced lasting increases in anxiety-like behaviour: role of GABA tone in initiation of brain and behavioural changes.
Adamec RE
J Psychopharmacol; 2000; 14(4):323-39. PubMed ID: 11198049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
